Mutations in HERC1 were detected in leukemias [25–27], breast cancers [28, 29] and, more recently, HERC1 has been associated with non-melanoma skin cancer through regulation of E6-mediated BAK degradation [15]. This evidence concerns the gene HERC1 and non-melanoma skin carcinoma.